Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...
Multiple system atrophy and Parkinson’s disease are progressive nervous system disorders that affect everyday movements. Multiple system atrophy is rarer and tends to progress more quickly.
One such debilitating and devastating condition is called Parkinson’s disease - a degenerative disorder that affects the brain and the central nervous system. Often this condition affects the ...
University of Southern California-led researchers have discovered the structural details of a brain receptor called GPR6, ...
Scientists suspect that tetanus bacteria are responsible for attacking the nervous system of ... individuals are to get diagnosed with Parkinson's disease.' Adults are given a tetanus vaccine ...
Summary of findings from the study and speculations from previous research. (Nishiwaki et al., npj Parkinson's Disease, 2024) ...
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.
A new study from a database of millions of veterans nationwide reveals a possible connection between hearing loss and ...
Pathogenic mutations in LRRK2 account for 4-5% of familial and 1-2% of sporadic Parkinson’s disease. 1,2 BIIB122 (DNL151) is a selective, central nervous system-penetrant small molecule inhibitor of ...
Blarcamesine’s safety profile indicates not requiring routine MRI monitoring, and the advantage of blarcamesine is that it is a small oral molecule that exerts clinical benefits on cognition and ...
SPR301 is a potential best-in-class gene therapy candidate that delivers a more stable, rationally engineered version of GCase, the enzyme ...